Astellas Acquires Xyphos to Boost Immuno-oncology Pipeline
Tokyo-based Astellas Pharma Inc . ALPMY announced that it has acquired privately-held, development-stage biotechnology company Xyphos Biosciences, Inc to boost its immuno-oncology pipeline. […]